Click here to submit Post PR News
Feedback Form
Per Page :

Dr Reddys Laboratories Limited

E-Mail: You need to be a registered (and logged in) user to view Dr Reddys Laboratories Limited email address

Total Articles : 2

Dr. Reddy’s Laboratories announces the launch of Daptomycin for Injection, 500mg/vial single-dose vial in the U.S. Market

Hyderabad, India and Princeton, NJ, USA. May 15, 2019— Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Daptomycin for Injection, 500mg/vial single-dose vial,  →
0 Views : 32

Dr. Reddy’s Laboratories to acquire select portfolio of the established products business of UCB in India

1 April 2015:  *    Dr. Reddy’s to buy the select established brands portfolio of UCB in India for INR 800 Crores (Euro 118 Mn) *    Dr. Reddy’s to strengthen its presence in Dermatology, Respiratory and Pediatrics Dr. Reddy’s  →
0 Views : 645



Create Free Account

........................................................................
You can create a free account with us to gain access to just released news and press releases about leading companies from across the world. Your free account can provide you with the latest industry and corporate information to help you take quick business decisions. With your free account, you can be amongst the first ones to know of the latest happenings. So Signup now !!.